National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Metabolic Syndrome Research Center, and Department of Metabolism and Endocrinology, Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3428-3441. doi: 10.1210/clinem/dgac570.
Time-restricted eating (TRE), which restricts food intake to a limited duration of the day, is a key regimen of intermittent fasting.
The aim of our study was to provide an up-to-date meta-analysis and systematic review to evaluate the efficacy of TRE on weight loss and other metabolic-related parameters in adults.
We searched PubMed, EMBASE, and the Cochrane Library for relevant studies published before February 26, 2022. Study duration of TRE was at least 4 weeks. Body weight and other metabolic-related continuous parameters were described as weighted mean difference (WMD) with 95% CI.
Seventeen randomized controlled trials involving 899 participants were analyzed. The pooled meta-analysis has shown that TRE contributed to a significant decrease in body weight with a WMD of -1.60 kg (95% CI -2.27 to -0.93) and fat mass with WMD -1.48 kg (95% CI -1.59 to -1.38). Subgroup analysis showed that TRE could reduce body weight and fat mass especially in overweight participants with WMD -1.43 kg (95% CI -2.05 to -0.81) and -1.56 kg (95% CI -1.67 to -1.44), respectively. TRE also showed beneficial effects on the lipid spectrum in overweight participants, including decreased levels of triglyceride (WMD -12.71 mg/dL, 95% CI -24.9 to -0.52), total cholesterol (WMD -6.45 mg/dL, 95% CI -7.40 to -5.49), and low-density lipoprotein cholesterol (WMD -7.0 mg/dL, 95% CI -9.74 to -4.25). However, compared with control, TRE had no significant effects on waist circumference, body mass index, glycosylated hemoglobin, or blood pressure.
This updated meta-analysis found that TRE may be an effective approach to improve the metabolic state of nonobese subjects, especially in overweight participants.
限时进食(TRE)限制一天中进食的时间,是间歇性禁食的关键方案。
本研究旨在提供最新的荟萃分析和系统评价,以评估 TRE 在成年人减肥和其他代谢相关参数方面的疗效。
我们检索了 PubMed、EMBASE 和 Cochrane 图书馆,以获取截至 2022 年 2 月 26 日发表的相关研究。TRE 的研究持续时间至少为 4 周。体重和其他代谢相关的连续参数以加权均数差(WMD)和 95%置信区间(CI)表示。
分析了 17 项涉及 899 名参与者的随机对照试验。荟萃分析结果表明,TRE 可显著降低体重,WMD 为-1.60kg(95%CI-2.27 至-0.93),脂肪量 WMD 为-1.48kg(95%CI-1.59 至-1.38)。亚组分析表明,TRE 尤其可以降低超重参与者的体重和脂肪量,WMD 分别为-1.43kg(95%CI-2.05 至-0.81)和-1.56kg(95%CI-1.67 至-1.44)。TRE 还对超重参与者的血脂谱产生有益影响,包括降低甘油三酯(WMD-12.71mg/dL,95%CI-24.9 至-0.52)、总胆固醇(WMD-6.45mg/dL,95%CI-7.40 至-5.49)和低密度脂蛋白胆固醇(WMD-7.0mg/dL,95%CI-9.74 至-4.25)水平。然而,与对照组相比,TRE 对腰围、体重指数、糖化血红蛋白或血压没有显著影响。
本更新的荟萃分析发现,TRE 可能是改善非肥胖受试者代谢状态的有效方法,尤其是在超重参与者中。